European regulators have approved Moderna Inc.’s novel combination flu and Covid shot, handing a victory to the embattled ...

The Food and Drug Administration rejected Moderna’s application for its mRNA-based flu vaccine, the drugmaker said Tuesday ...

After the FDA’s decision to reject a review of Moderna’s mRNA-1010 flu shot, executives explain what Americans will miss out ...

The FDA will review Moderna’s new mRNA flu vaccine after reversing course, raising fresh concerns about potential setbacks ...

The decision, which shocked company officials, comes as the FDA says it will take a stricter approach to federal vaccine approvals.

Moderna said it met with the FDA on Tuesday to discuss the vaccine and afterward, the U.S. regulator accepted a revised ...

The FDA agreed to review Moderna’s experimental mRNA influenza vaccine after Moderna resubmitted its application with modifications.

Moderna says the U.S. Food and Drug Administration (FDA) has agreed to review its influenza ‌vaccine, reversing an earlier decision to reject the application, following modifications from the company.

Arbutus alleges that Moderna’s COVID-19 vaccine infringes on patents protecting its lipid nanoparticle delivery technology.

mRNAワクチンのパイオニアであるモデルナがmRNAインフルエンザワクチンの審査を医薬品の規制を担当するアメリカ食品医薬品局(FDA)に申請したところ、これを拒否されるという事態が起きました。しかし、FDAはこの拒否を撤回しています。